ElaineTLamMDFACP

Oncology • Aurora, CO

Genitourinary Oncology

Associate Professor, Medicine, University of Colorado School of Medicine

Join to view full profile

Dr. Lam is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lam's full profile

Already have an account?

Office
1665 Aurora Ct
Aurora, CO 80045
Phone+1 720-848-0170

Fax+1 720-848-0180
Is this information wrong?

Summary

Dr. Elaine Lam is a medical oncologist in Aurora, CO and is affiliated with University of Colorado Hospital. She received her medical degree from University of Colorado Denver School of Medicine and has been in practice 14 years. She specializes in genitourinary medical oncology.

Education & Training

Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2007 - 2010
University of ColoradoResidency, Internal Medicine, 2003 - 2006
University of Colorado School of Medicine Anschutz Medical CampusClass of 2003

Certifications & Licensure

CO State Medical License 1998 - 2025
WY State Medical License 2021 - 2024
OH State Medical License 2007 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Fellow of the American College of Physicians American College of Physicians, 2018

Clinical Trials

S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Active, not recruiting
Phase 3
Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma Start of enrollment: 2017 Aug 01
Active, not recruiting
Phase 2
A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney Start of enrollment: 2017 Jul 07
Completed
Phase 3
Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma Start of enrollment: 2017 Sep 28
Active, not recruiting
Phase 1, Phase 2
An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread Start of enrollment: 2018 Mar 08
Active, not recruiting
Phase 1, Phase 2
A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC) Start of enrollment: 2019 Jan 08
Active, not recruiting
Phase 2
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study Start of enrollment: 2019 Jun 07
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer.
Wiesen, B., Atwell, M., Leavitt, C., Clark, N., Kessler, E., Lam, E., Flaig, T., Kukreja, J., Kim, S., Maroni, P., Cost, N.> ;JCO Oncology Practice. 2024 Mar 1
1 citations
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
Gilbert, D., Matteo Santoni, Zin W Myint, Thomas Büttner, Hideki Takeshita, Yohei Okada, Elaine T Lam, Danielle Gilbert, Zsófia Küronya, Deniz Tural, Renate Pichler, E...> ;Cancer Immunology, Immunotherapy. 2023 Sep 1
A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma.
Elizabeth R Kessler, Eryn Callihan, Junxiao Hu, Corbin Eule, Geetika Srivastava, Douglas J Kemme, Praveena Iruku, Vishal Rana, James Moore, Steven R Schuster, Mali Ami...> ;Cancer Research Communications. 2023 Jun 1
4 citations
Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors.
Junxiao Hu, Theresa Medina, Elizabeth R Kessler, Elaine T Lam, Gilbert, D., Danielle Gilbert> ;Human Vaccines & Immunotherapeutics. 2023 Dec 31
Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study.
Corbin J Eule, Junxiao Hu, Sulaiman Al-Saad, Katharine Collier, Patrick Boland, Akeem R Lewis, Rana R McKay, Vivek Narayan, Dominick Bosse, Amir Mortazavi, Tracy L Ros...> ;Clinical Genitourinary Cancer. 2023 Aug 1
2 citations
Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences.
Matteo Santoni, Javier Molina-Cerrillo, Giorgio Santoni, Elaine T Lam, Francesco Massari, Veronica Mollica, Giulia Mazzaschi, Bernardo L Rapoport, Enrique Grande, Seba...> ;Cancers. 2023 Jan 7
Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma.
Bourlon, M., Remolina-Bonilla, Y., Acosta-Medina, A., Saldivar-Oviedo, B., Perez-Silva, A., Martinez-Ibarra, N., Castro-Alonso, F., Martín-Aguilar, A., Rivera-Rivera, ...> ;Frontiers in Oncology. 2023 Jan 1
2 citations
Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterations.
Corbin J Eule, Thomas W Flaig, Katy Wong, Ryon Graf, Elaine T Lam> ;Prostate Cancer and Prostatic Diseases. 2023 Mar 1
5 citations
A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignancies.
Wen Wee Ma, Jenny J Li, Nilofer S Azad, Elaine T Lam, Jennifer R Diamond, Grace K Dy, Mateusz Opyrchal, Jay Zhi, Douglas Kramer, Wing-Kai Chan, David Cutler, Rudolf Kw...> ;Cancer Chemotherapy and Pharmacology. 2022 Jul 1
7 citations
ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study.
Mark N Stein, Lawrence Fong, Ronald Tutrone, Anthony Mega, Elaine T Lam, Megan Parsi, Surya Vangala, Andres A Gutierrez, Naomi B Haas> ;The Oncologist. 2022 Jun 8
5 citations
Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma.
Bradley A McGregor, Wanling Xie, Elio Adib, Walter M Stadler, Yousef Zakharia, Aijai Alva, M Dror Michaelson, Shilpa Gupta, Elaine T Lam, Subrina Farah, Amin H Nassar,...> ;JCO Precision Oncology. 2022 Feb 1
8 citations
Association of Neutrophil-to-Lymphocyte Ratio With Efficacy of First-Line Avelumab Plus Axitinib vs Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled i...
Mehmet Asim Bilen, Brian I. Rini, Martin H. Voss, James Larkin, John B. A. G. Haanen, Laurence Albiges, Lance C. Pagliaro, Eric Voog, Elaine T. Lam, Nikolay Kislov, Br...> ;Clinical Cancer Research. 2021 Nov 17
34 citations
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma
Laure Hirsch, Nieves Martinez Chanza, Subrina Farah, Wanling Xie, Ronan Flippot, David A. Braun, Nityam Rathi, Jonathan Thouvenin, Katharine Collier, Emmanuel Seront, ...> ;JAMA Oncology. 2021 Oct 21
1 citations
Spontaneous regression of an extragonadal seminomatous germ cell tumor.
Cassandra Duarte, Alison D. Sheridan, Francisco G. La Rosa, Martin D. McCarter, Nicholas G. Cost, Steven Emmons, Elaine T. Lam, Gilbert, D., Danielle M. Gilbert> ;Cancer Treatment and Research Communications. 2021 Jan 1
Do we need skin toxicity? Association of immune checkpoint inhibitor and tyrosine kinase inhibitor-related cutaneous adverse events with outcomes in metastatic renal c...
Eduardo Corona-Rodarte, Antonio Olivas-Martinez, Yuly A Remolina-Bonilla, Judith Domínguez-Cherit, Elaine T. Lam, Maria T Bourlon> ;International Journal of Dermatology. 2021 Apr 19
1 citations
A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with ad...
Wen Wee Ma, Mojun Zhu, Elaine T. Lam, Jennifer R. Diamond, Grace K. Dy, George A. Fisher, Laura W. Goff, Steven R. Alberts, Lynne A. Bui, Akhil Sanghal, Mudgal Kotheka...> ;Cancer Chemotherapy and Pharmacology. 2021 Feb 26
8 citations
A Cost-Effectiveness Analysis of Nivolumab plus Ipilimumab Versus Pembrolizumab plus Axitinib and Versus Avelumab plus Axitinib in First-Line Treatment of Advanced Ren...
Rebecca C. Shay, Andrew Nicklawsky, Dexiang Gao, Elaine T. Lam> ;Clinical Genitourinary Cancer. 2021 Feb 7
7 citations
Metastatic Mature Teratoma and Growing Teratoma Syndrome in Patients with Testicular Non-Seminomatous Germ Cell Tumors
Daniel B. Green, Francisco G. La Rosa, Paul G. Craig, Francesca Khani, Elaine T. Lam> ;Korean Journal of Radiology. 2021 Oct 1
2 citations
Tumor flare of brain metastases upon dose interruption of sunitinib in a patient with metastatic renal cell carcinoma
Mali Amirault, Sylvia Choo, Timothy V. Waxweiler, Sarah D. Weisdack, Kathryn Breaker, Thomas W. Flaig, Elaine T. Lam> ;Cancer Treatment and Research Communications. 2021 Jan 1
39 citations
Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.
Vogelzang, N., Olsen, M., McFarlane, J., Arrowsmith, E., Bauer, T., Jain, R., Somer, B., Lam, E., Kochenderfer, M., Molina, A., Doshi, G., Lingerfelt, B., Hauke, R., G...> ;Clinical Genitourinary Cancer. 2020 Dec 1
161 citations
Kidney cancer, version 1.2021: Featured updates to the nccn guidelines
Robert J. Motzer, Eric Jonasch, Shawna L. Boyle, Maria I. Carlo, Brandon Manley, Neeraj Agarwal, Ajjai Alva, Katy Beckermann, Toni K. Choueiri, Brian A. Costello, Itha...> ;Journal of the National Comprehensive Cancer Network. 2020 Sep 1
6 citations
Prostate Cancer Central Nervous System Metastasis in a Contemporary Cohort.
Peter Boxley, Derek E. Smith, Dexiang Gao, Elizabeth R. Kessler, Benjamin Echalier, Brandon Bernard, D. Ryan Ormond, Elaine T. Lam, Brian D. Kavanagh, Thomas W. Flaig> ;Clinical Genitourinary Cancer. 2021 Jun 1
6 citations
Preclinical and Dose-Finding Phase I Trial Results of Combined Treatment with a TORC1/2 Inhibitor (TAK-228) and Aurora A Kinase Inhibitor (Alisertib) in Solid Tumors.
S. Lindsey Davis, Anastasia A. Ionkina, Stacey M. Bagby, James D. Orth, Brian Gittleman, Joshua M. Marcus, Elaine T. Lam, Bradley R. Corr, Cindy L. O'Bryant, Ashley E....> ;Clinical Cancer Research. 2020 May 15
1 citations
Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab
Yuly A Remolina-Bonilla, Brenda Jimenez-Franco, Elaine T. Lam, Maria T Bourlon> ;Oncology. 2020 May 13
17 citations
Patient-reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma
Sumanta K. Pal, David F. McDermott, Michael B. Atkins, Bernard Escudier, Brian I. Rini, Robert J. Motzer, Lawrence Fong, Richard W. Joseph, Stéphane Oudard, Alain Rava...> ;BJU International. 2020 Jul 1
Join now to see all